IndraLab
Statements
sparser
"By mirroring the mode of action of the endogenous form, anakinra inhibits the binding of IL-1α and IL-1β to IL-1R, and it has been approved for the treatment of rheumatoid arthritis, adult-onset Still’s disease, and certain periodic fever syndromes (such as familial Mediterranean fever)."
sparser
"Initiating intracellular signaling via the IL-1R1 system is a multistep process involving: IL-1α or IL-1β binding to the extracellular domain of IL-1R1, recruitment of accessory proteins (e.g., the co-receptor IL-1R1 accessory protein (IL-1RAcP)), formation of a receptor heterodimeric complex (comprised of IL-1α or IL-1β, IL-1RI, and IL-1RAcP), and assemblage of intracellular adaptor proteins."